Streamlining Specialty Drug Prior Auth in Hawaii

The Dual Challenge of Specialty Drug PA in Hawaii

Specialty drugs, including biologics, biosimilars, and high-cost infused agents, frequently fall under either the medical or pharmacy benefit, a distinction that critically impacts the prior authorization pathway. For providers operating in Hawaii, this requires navigating the specific policies of various commercial payers and Medicaid managed care organizations, each with distinct submission channels and clinical criteria. Misclassification can lead to significant delays and denials, impacting patient access to essential treatments.

Key Workflow Complexities for Specialty Drugs in Hawaii

• **Benefit-Side Determination:** Accurately identifying whether a specialty drug falls under the medical or pharmacy benefit for a specific payer and patient in Hawaii.
• **Site-of-Care Policies:** Adhering to payer-specific site-of-care requirements for infused medical-benefit drugs, which may favor infusion centers over hospital outpatient departments.
• **Step-Therapy Documentation:** Providing comprehensive prior-line therapy history to satisfy step-therapy protocols, often required for biologic approvals.
• **Specialty Pharmacy Fulfillment:** Coordinating the post-approval handoff to the correct specialty pharmacy partner for patient-administered drugs.
• **Copay Assistance Navigation:** Managing manufacturer copay-assistance programs while adhering to regulations, particularly for Medicare patients.

Klivira's Automated Approach to Specialty Drug PA

Klivira's platform streamlines specialty drug prior authorization by automating critical steps across both medical and pharmacy benefits. Our policy engine precisely identifies the correct benefit side per drug, per payer, and per patient context, routing submissions through appropriate channels like NCPDP SCRIPT ePA for pharmacy benefits or X12 278 and Da Vinci PAS for medical benefits. This automation minimizes manual errors and accelerates time-to-therapy.

How Klivira Addresses Hawaii-Specific PA Challenges

• **Automated Benefit-Side Routing:** Intelligently directs specialty drug PA requests to the correct medical or pharmacy channel, accommodating diverse payer requirements prevalent in Hawaii.
• **Compliant Documentation:** Gathers and formats necessary clinical data, including step-therapy history, to meet payer criteria and state-level PA mandates where applicable.
• **Streamlined Specialty Pharmacy Handoff:** Coordinates post-approval fulfillment workflows with specialty pharmacies serving patients across Hawaii, reducing administrative burden.
• **EMR Integration:** Connects with existing EMR systems to extract relevant patient data, ensuring comprehensive and accurate submissions for organizations in Hawaii.
• **Site-of-Care Alignment:** Incorporates payer site-of-care policies into the PA workflow, flagging potential mismatches before submission for medical-benefit drugs.

Leveraging Industry Standards for Efficiency

Klivira's platform is built on industry-recognized standards to ensure robust and interoperable prior authorization workflows. For pharmacy-benefit specialty drugs, we leverage NCPDP SCRIPT for electronic prior authorization (ePA). Medical-benefit submissions utilize FHIR MedicationRequest for clinical data exchange, supporting Da Vinci PAS conformant submissions where available, alongside traditional X12 278 EDI transactions. This multi-standard approach ensures comprehensive connectivity with payers operating in Hawaii.